U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Vericiguat (Verquvo): CADTH Reimbursement Recommendation: Indication: For the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction who are stabilized after a recent heart failure decompensation event requiring hospitalization and/or IV diuretic therapy. Vericiguat should be used in combination with standard of care therapy for heart failure [Internet].

Vericiguat (Verquvo): CADTH Reimbursement Recommendation: Indication: For the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction who are stabilized after a recent heart failure decompensation event requiring hospitalization and/or IV diuretic therapy. Vericiguat should be used in combination with standard of care therapy for heart failure [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jun.

Table of contents


Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...